Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease

Journal of Cardiology

Volumn 54, Issue 2, 2009, Pages 262-272

  Kosaka, Toshimitsu ^a   Nakagawa, Masayasu ^b   Ishida, Masaru ^a   Iino, Kenji ^a   Watanabe, Hiroyuki ^a   Hasegawa, Hitoshi ^a   Ito, Hiroshi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA CITY HOSPITAL   (Japan)

Author keywords

Cardiac sympathetic activity; Cilnidipine; Diastolic function; Hypertension; Radionuclide imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CILNIDIPINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NIFEDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; HEART RATE; HUMAN; MALE; MONOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC TONE;

ADULT; AGED; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; FEMALE; HEART; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NICARDIPINE; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 70349251210     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.05.012     Document Type: Article

References (40)

1. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
2. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., and Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114 (1991) 345-352
3. Devereux R.B., de Simone G., Koren M.J., Roman M.J., and Laragh J.H. Left ventricular mass as a predictor of development of hypertension. Am J Hypertens 4 (1991) 603S-607S
4. Cuocolo A., Sax F.L., Brush J.E., Maron B.J., Bacharach S.L., and Bonow R.O. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension Diastolic mechanisms for systolic dysfunction during exercise. Circulation 81 (1990) 978-986
5. Aeschbacher B.C., Hutter D., Fuhrer J., Weidmann P., Delacrétaz E., and Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 14 (2001) 106-113
6. Devereux R.B., Pickering T.G., Harshfield G.A., Kleinert H.D., Denby L., Clark L., Pregibon D., Jason M., Kleiner B., Borer J.S., and Laragh J.H. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 68 (1983) 470-476
7. Patel M.B., Stewart J.M., Loud A.V., Anversa P., Wang J., Fiegel L., and Hintze T.H. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 84 (1991) 2091-2100
8. Kelm M., Schäfer S., Mingers S., Heydthausen M., Vogt M., Motz W., and Strauer B.E. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14 (1996) 1357-1364
9. Isobe N., Taniguchi K., Oshima S., Ono Z., Adachi H., Toyama T., Naito S., Hoshizaki H., and Kamiyama H. Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease. Circ J 66 (2002) 993-999
10. Terpstra W.F., May J.F., Smit A.J., de Graeff P.A., Havinga T.K., van den Veur E., Schuurman F.H., Meyboom-de Jong B., and Crijns H.J. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. J Hypertens 19 (2001) 303-309
11. Devereux R.B., Palmieri V., Sharpe N., De Quattro V., Bella J.N., de Simone G., Walker J.F., Hahn R.T., and Dahlöf B. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial. Circulation 104 (2001) 1248-1254
12. 2+ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 280 (1997) 1184-1191
13. 2+ channels. Eur J Pharmacol 373 (1999) 93-100
14. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 239 (1988) 57-61
15. Onose Y., Oki T., Yamada H., Manabe K., Kageji Y., Matsuoka M., Yamamoto T., Tabata T., Wakatsuki T., and Ito S. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging. Jpn Circ J 65 (2001) 305-309
16. Takami T., and Shigematsu M. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension. Clin Exp Hypertens 25 (2003) 525-535
17. Aurigemma G.P., Zile M.R., and Gaasch W.H. Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Am Heart J 148 (2004) e12
18. Nishimura R.A., and Appleton C.P. Diastology: beyond E and A. J Am Coll Cardiol 27 (1996) 372-374
19. Germano G., Kavanagh P.B., Su H.T., Mzzanti M., Kiat H., Hachamovitch R., Van Train K.F., Areeda J.S., and Berman D.S. Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. J Nucl Med 36 (1995) 1107-1114
20. Germano G., Kiat H., Kavanagh P.B., Moriei M., Mazzanti M., Su H.T., Van Train K.F., and Berman D.S. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
21. 99mTc-sestamibi gated myocardial perfusion SPECT: normal values. J Nucl Med 46 (2005) 1102-1108
22. Wieland D.M., Wu J., Brown L.E., Mangner T.J., Swanson D.P., and Beierwaltes W.H. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I] iodobenzylguanidine. J Nucl Med 21 (1980) 349-353
23. Wieland D.M., Brown L.E., Rogers W.L., Worthington K.C., Wu J.L., Clinthorne N.H., Otto C.A., Swanson D.P., and Beierwaltes W.H. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22 (1981) 22-31
24. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., and Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
25. Teichholz L.E., Kreulen T., Herman M.V., and Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37 (1976) 7-11
26. Minami J., Kawano Y., Makino Y., Matsuoka H., and Takishita S. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Br J Clin Pharmacol 50 (2000) 615-620
27. Yamagishi T. Beneficial effect of cilnidipine on morning hypertension and white-coat-effect in patients with essential hypertension. Hypertens Res 29 (2006) 339-344
28. Tomiyama H., Kimura Y., Kuwabara Y., Maruyama C., Yoshida Y., Kuwata S., Kinouchi T., Yoshida H., and Doba N. Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine. Hypertens Res 24 (2001) 679-684
29. Sakata K., Shirotani M., Yoshida H., Nawada R., Obayashi K., Togi K., and Miho N. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 33 (1999) 1447-1452
30. Bonow R.O., Bacharach S.L., Green M.S., Kent K.M., Rosing D.R., Lipson L.C., Leon M.B., and Epstein S.E. Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation 64 (1981) 315-323
31. 99mTc-tetrofosmin myocardial SPET. Eur J Nucl Med 28 (2001) 593-601
32. Kumita S., Cho K., Nakajo H., Toba M., Uwamori M., Mizumura S., Kumazaki T., Sano J., Sakai S., and Munakata K. Assessment of left ventricular diastolic function with electrocardiography-gated myocardial perfusion SPECT: comparison with multigated equilibrium radionuclide angiography. J Nucl Cardiol 8 (2001) 568-574
33. Patel D., Robinson V.J.B., Arteaga R.B., and Thornton J.W. Diastolic filling parameters derived from myocardial perfusion imaging can predict left ventricular end-diastolic pressure at subsequent cardiac catheterization. J Nucl Med 49 (2008) 746-751
34. Yamada J., Tomiyama H., Matsumoto C., Yoshida M., Shiina K., and Yamashina A. Effects of azelnidipine on the autonomic functions and its influence on arterial stiffness and endothelial functions. J Cardiol 51 (2008) 114-120
35. Eguchi K., Tomizawa H., Ishikawa J., Hoshide S., Fukuda T., Numao T., Shimada K., and Kario K. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol 49 (2007) 394-400
36. Ohshima S., Isobe S., Izawa H., Nanasato M., Ando A., Yamada A., Yamada K., Kato T.S., Obata K., Noda A., Nishizawa T., Kato K., Nagata K., Okumura K., Murohara T., et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 46 (2005) 2061-2068
37. Nagai H., Minatoguchi S., Chen X.H., Wang N., Arai M., Uno Y., Lu C., Misao Y., Onogi H., Kobayashi H., Takemura G., Maruyama R., Fujiwara T., and Fujiwara H. Cilnidipine, an N + L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction. Hypertens Res 28 (2005) 361-368
38. Logeart D., Vinet L., Ragot T., Heimburger M., Louedec L., Michel J.B., Escoubet B., and Mercadier J.J. Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study. Am J Physiol Heart Circ Physiol 291 (2006) H1773-H1779
39. Lim Y.J., Yamamoto K., Ichikawa M., Iwata A., Hayashi T., Nakata T., Masuyama T., and Mishima M. Elevation of the ratio of transmitral E velocity to early diastolic mitral annular velocity continues even after recovery from acute stage in patients with diastolic heart failure. J Cardiol 52 (2008) 254-260
40. Su H.N., Lin T.H., Voon W.C., Lee K.T., Chu C.S., Lai W.T., and Sheu S.H. Differentiation of left ventricular diastolic dysfunction, identification of pseudonormal/restrictive mitral inflow pattern and determination of left ventricular filling pressure by Tei index obtained from tissue Doppler echocardiography. Echocardiography 23 (2006) 287-294